Volume 2, Issue 1 (2023)                   GMJM 2023, 2(1): 19-22 | Back to browse issues page
Article Type:
Descriptive & Survey |
Subject:

Print XML PDF HTML


History

How to cite this article
L. S. Levels of Serum Calcium and Vitamin D in Children with Type 2 Diabetes. GMJM 2023; 2 (1) :19-22
URL: http://gmedicine.de/article-2-198-en.html
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Rights and permissions
Authors Saboktakin L. *
Department of Otorhinolaryngology, Tabriz University Of medical Sciences, Tabriz, Iran
* Corresponding Author Address: Department of Otorhinolaryngology, Tabriz University of Medical Sciences, Tabriz, Iran. (lida.saboktanin@gmail.com)
Abstract   (777 Views)
Aims: Due to the fact that vitamin D and calcium in diabetes can play a major role in diabetes, and informed of preventive measures. the present study aimed to evaluate the serum calcium and vitamin D status in patients with Type 2 Diabetes.
Instrument and Methods: This cross-sectional descriptive study was conducted in 2018 with participation of 122 children with type 2 diabetes at Tabriz University of Medical Sciences.
Findings: The venous blood samples were taken from all children to serum vitamin D and calcium levels and its levels were evaluated with diabetes. The mean serum calcium level was 9.45±0.85mg/dl and the average serum levels of vitamin D were 10.99±1.14ng/ml. Serum vitamin D levels were divided into three levels of severe deficiency, mild and natural deficiency; Also, serum calcium levels were divided into two normal and abnormal levels. Body mass index and diabetes time based on vitamin d and calcium group showed a significant difference between groups; This means that the low serum levels of vitamin D and calcium are predictors of diabetes in children.
Conclustion: Vitamin D supplementation in diabetic children in winter, when the rate of deficiency is very high, can be a practical solution to reduce the problems caused by this deficiency.
 
Keywords:
|   |   Full-Text (HTML)  (146 Views)  

References
1. Gupta G, de Jesus Andreoli Pinto T, Chellappan DK, Mishra A, Malipeddi H, Dua K. A clinical update on metformin and lung cancer in diabetic patients. Panminerva Med. 2018;60(2):70-5. [Link] [DOI:10.23736/S0031-0808.18.03394-3]
2. Xin GL, Khee YP, Ying TY, Chellian J, Gupta G,. Kunnath AP, et al. Current status on immunological therapies for type 1 Diabetes Mellitus. Curr Diab Rep. 2019;19(5);22. [Link] [DOI:10.1007/s11892-019-1144-3]
3. Miettinen ME, Smart MC, Kinnunen L, Harjutsalo V, Reinert-Hartwall L, Ylivinkka I, et al. Genetic determinants of serum 25-hydroxyvitamin D concentration during pregnancy and type 1 diabetes in the child. PloS One. 2017;12:e0184942. [Link] [DOI:10.1371/journal.pone.0184942]
4. Penna-Martinez M, Badenhoop K. Inherited variation in Vitamin D Genes and Type 1 Diabetes predisposition. Genes. 2017;8(4):125. [Link] [DOI:10.3390/genes8040125]
5. Nam HK, Rhie YJ, Lee YH. Vitamin D level and gene polymorphisms in Korean children with type 1 diabetes. Pediatric Diabetes, 2019;20(6):750-8. [Link] [DOI:10.1111/pedi.12878]
6. Ahmed AE, Sakhr HM, Hassan MH, El-Amir MI, Ameen HH. Vitamin D receptor rs7975232, rs731236 and rs1544410 single nucleotide polymorphisms, and 25-hydroxyvitamin D levels in Egyptian children with type 1 diabetes mellitus: effect of vitamin D co-therapy. Diabetes Metabolic Syndr Obes. 2019;12:703-16. [Link] [DOI:10.2147/DMSO.S201525]
7. Habibian N, Amoli MM, Abbasi F, Rabbani A, Alipour A, Sayarifard F, et al. Role of vitamin D and vitamin D receptor gene polymorphisms on residual beta cell function in children with type 1 diabetes mellitus. Pharmacological Rep. 2019;71:282-8. [Link] [DOI:10.1016/j.pharep.2018.12.012]
8. Rasoul MA, Haider MZ, Al-Mahdi M, Al-Kandari H, Dhaunsi GS. Relationship of four vitamin D receptor gene polymorphisms with type 1 diabetes mellitus susceptibility in Kuwaiti children. BMC Pediatrics. 2019;19:71. [Link] [DOI:10.1186/s12887-019-1448-0]
9. Ali R, Fawzy I, Mohsen I, Settin A. Evaluation of vitamin D receptor gene polymorphisms (Fok-I and Bsm-I) in T1DM Saudi children. J Clin Lab Anal. 2018;32:e22397. [Link] [DOI:10.1002/jcla.22397]
10. Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: Elaboration and explanation. BMJ. 2015;349:g7647. [Link] [DOI:10.1136/bmj.g7647]
11. Zhang Q, Jin Y, Li X, Peng X, Peng N, Song J, et al. Plasminogen activator inhibitor-1 (PAI-1) 4G/5G promoter polymorphisms and risk of venous thromboembolism-a meta-analysis and systematic review. VASA. 2020;49(2):141-6. [Link] [DOI:10.1024/0301-1526/a000839]
12. Zhang W, Xu Y. Association between Vitamin D receptor gene polymorphism rs2228570 and allergic rhinitis. Pharmgenomics Pers Med. 2020;13:327-35. [Link] [DOI:10.2147/PGPM.S262402]
13. Al-Eisa AA, Haider MZ. Vitamin D receptor gene TaqI and Apal polymorphisms and steroid responsiveness in childhood idiopathic nephrotic syndrome. Int J Nephrol Renovasc Dis. 2016;9:187-92. [Link] [DOI:10.2147/IJNRD.S111538]
14. Rejnmark L, Bislev LS, Cashman KD, Eiríksdottir G, Gaksch M, Grübler M, et al. Non-skeletal health effects of vitamin D supplementation: A systematic review on findings from meta-analyses summarizing trial data. PLoS One. 2017;12:e0180512. [Link] [DOI:10.1371/journal.pone.0180512]
15. Cashman KD, Dowling KG, Škrabáková Z, Gonzalez-Gross M, Valtueña J, De Henauw S, et al. Vitamin D deficiency in Europe: pandemic?. Am J Clin Nutr. 2016;103:1033-44. [Link] [DOI:10.3945/ajcn.115.120873]
16. Sethuraman U, Zidan MA, Hanks L, Bagheri M, Ashraf A. Impact of vitamin D treatment on 25 hydroxy vitamin D levels and insulin homeostasis in obese African American adolescents in a randomized trial. J Clin Transl Endocrinol. 2018;12:13-9. [Link] [DOI:10.1016/j.jcte.2018.03.002]
17. Magge SN, Prasad D, Zemel BS, Kelly A. Vitamin D3 supplementation in obese, African-American, vitamin D deficient adolescents. J Clin Transl Endocrinol. 2018;12:1-7. [Link] [DOI:10.1016/j.jcte.2018.03.001]
18. Brar PC, Contreras M, Fan X, Visavachaipan N. Effect of one time high dose "stoss therapy" of vitamin D on glucose homeostasis in high risk obese adolescents. Arch Endocrinol Metab. 2018;62(2):193-200. [Link] [DOI:10.20945/2359-3997000000024]
19. Smith TJ, Tripkovic L, Hauger H, Damsgaard CT, Mølgaard C, Lanham-New SA, et al. Winter cholecalciferol supplementation at 51°n has no effect on markers of cardiometabolic risk in healthy adolescents aged 14-18 years. J Nutr. 2018;148(8):1269-75. [Link] [DOI:10.1093/jn/nxy079]
20. Hauger H, Mølgaard C, Mortensen C, Ritz C, Frøkiær H, Smith TJ, et al. Winter cholecalciferol supplementation at 55°n has no effect on markers of cardiometabolic risk in healthy children aged 4-8 years. J Nutr. 2018;148(8):1261-8. [Link] [DOI:10.1093/jn/nxy080]
21. Ferira AJ, Laing EM, Hausman DB, Hall DB, McCabe GP, Martin BR, et al. Vitamin D Supplementation Does Not Impact Insulin Resistance in Black and White Children. J Clin Endocrinol Metab. 2016;101(4):1710-8. [Link] [DOI:10.1210/jc.2015-3687]